Severity: Warning
Message: fopen(/var/lib/php/sessions/ci_sessions5au178f6qe82avrt12h3m2sk90b45j7): Failed to open stream: No space left on device
Filename: drivers/Session_files_driver.php
Line Number: 177
Backtrace:
File: /var/www/html/index.php
Line: 316
Function: require_once
Severity: Warning
Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)
Filename: Session/Session.php
Line Number: 137
Backtrace:
File: /var/www/html/index.php
Line: 316
Function: require_once
Lip and oral cavity squamous cell carcinoma (SCC) develop from progressive dysplasia of these mucosal structures. The cancers are often preceded by premalignant lesions, and any nonhealing ulcers of the lip or oral cavity should be biopsied. Some risk factors for these 2 subsites overlap and include tobacco use, alcohol use, and an immunocompromised state. Lip and oral cavity SCC are clinically staged based on physical examination and imaging. The 5-year overall survival for early-stage lip and oral cavity SCC is around 70% to 90% but decreases to about 50% for late-stage disease.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.hoc.2021.05.003 | DOI Listing |
Head Neck Pathol
March 2025
Department of Biosciences and Oral Diagnosis, Institute of Science and Technology, São Paulo State University (UNESP), Av. Eng. Francisco José Longo, 777 - Jardim São Dimas, São José dos Campos, SP, CEP 12245-000, Brazil.
Background And Purpose: Described in 2013, intraneural pseudoperineuriomatous proliferations (IPP) present perineurial cells concentrically surrounding the axon-Schwann cell complexes, forming pseudo-onion bulbs. Different from intraneural perineuriomas, rare neoplasms with differentiation of perineural cells, IPP are reactive, associated with fibrosis, and frequently diagnosed histologically as traumatic neuroma (TN). The aim of this study was to characterize IPP by exploring its clinicopathological features and differentiating it from the main neural lesions that are part of the histopathological differential diagnosis through a retrospective study in six Brazilian Oral Pathology laboratories.
View Article and Find Full Text PDFBr Dent J
March 2025
Consultant Dermatologist, Wrexham Maelor Hospital, Croesnewydd Road, Wrexham, LL13 7TD, UK.
J Oral Biol Craniofac Res
February 2025
SRM Dental College, Ramapuram Campus Chennai, Tamil Nadu, India.
Background: The awareness of the symbiotic correlation between folic acid and its role in preventing orofacial clefts in pregnant mothers needs to be established during the early gestational period, proving that consumption in both dietary and supplementation forms has positive effects on the mother and the developing fetus.
Aim: The present study raises awareness of the benefits and use of folic acid supplementation in the early phases of gestation.
Materials And Methods: A questionnaire survey was conducted over 9 months.
BMC Cancer
March 2025
Department of Surgery, Aga Khan University, Karachi, 74800, Pakistan.
Introduction: Pakistan has a high prevalence of oral cavity cancer (OCC) with a significant recurrence rate. This study aims to explore the factors associated with OCC recurrence in Karachi, Pakistan.
Methods: This cross-sectional study was conducted at the Aga Khan University Hospital (AKUH) Karachi, Pakistan, using data from the AKUH Cancer Registry.
J Craniomaxillofac Surg
March 2025
Department of Maxillofacial Surgery, Clinic of Pediatric Surgery, Institute of Mother and Child, Ul. Kasprzaka 17a, 01-211, Warsaw, Poland. Electronic address:
Palatal morphology in patients with clefts can be accurately assessed during the presurgical period, providing insights into how cleft type affect palatal development. These early observations are unbiased by treatment, making them broadly applicable. This study aimed to identify differences in palatal morphology among untreated patients with various cleft types before surgery.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!